Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society
|
June 6, 2020
Minimal clinically important difference for asthma endpoints: an expert consensus report
Matteo Bonini, Marcello Di Paolo, Diego Bagnasco, et al.
Pulmonary Pharmacology & Therapeutics
|
September 2, 2019
One year of mepolizumab. Efficacy and safety in real-life in Italy
Diego Bagnasco, Marco Caminati, Francesco Menzella, et al.
Life (Basel, Switzerland)
|
July 29, 2023
Prevalence of Long COVID Symptoms Related to SARS-CoV-2 Strains
Teresita Aloè, Federica Novelli, Gianfranco Puppo, et al.
Allergy
|
November 28, 2019
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life
Diego Bagnasco, Alessandro Massolo, Marco Bonavia, et al.
Respiratory Medicine
|
September 12, 2020
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis
Diego Bagnasco, Luisa Brussino, Marco Bonavia, et al.
Clinical and Molecular Allergy : CMA
|
June 24, 2015
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly
Nicola Scichilone, Maria T Ventura, Matteo Bonini, et al.
Allergy
|
November 18, 2022
Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study
Gennaro Liccardi, Maria Beatrice Bilò, Luigino Calzetta, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 17, 2020
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian multicenter study
Gennaro Liccardi, Luigino Calzetta, Maria Beatrice Bilò, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 26, 2015
Non respiratory symptoms in asthma as possible predictors of exacerbations
Gennaro Liccardi, Gennaro Baldi, Adriano Berra, et al.
Biomedicines
|
September 28, 2023
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
Diego Bagnasco, Stefania Nicola, Elisa Testino, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
European Respiratory Review : an Official Journal of the European Respiratory Society
|
June 6, 2020
Minimal clinically important difference for asthma endpoints: an expert consensus report
Matteo Bonini, Marcello Di Paolo, Diego Bagnasco, et al.
Pulmonary Pharmacology & Therapeutics
|
September 2, 2019
One year of mepolizumab. Efficacy and safety in real-life in Italy
Diego Bagnasco, Marco Caminati, Francesco Menzella, et al.
Life (Basel, Switzerland)
|
July 29, 2023
Prevalence of Long COVID Symptoms Related to SARS-CoV-2 Strains
Teresita Aloè, Federica Novelli, Gianfranco Puppo, et al.
Allergy
|
November 28, 2019
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life
Diego Bagnasco, Alessandro Massolo, Marco Bonavia, et al.
Respiratory Medicine
|
September 12, 2020
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis
Diego Bagnasco, Luisa Brussino, Marco Bonavia, et al.
Clinical and Molecular Allergy : CMA
|
June 24, 2015
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly
Nicola Scichilone, Maria T Ventura, Matteo Bonini, et al.
Allergy
|
November 18, 2022
Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study
Gennaro Liccardi, Maria Beatrice Bilò, Luigino Calzetta, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 17, 2020
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian multicenter study
Gennaro Liccardi, Luigino Calzetta, Maria Beatrice Bilò, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 26, 2015
Non respiratory symptoms in asthma as possible predictors of exacerbations
Gennaro Liccardi, Gennaro Baldi, Adriano Berra, et al.
Biomedicines
|
September 28, 2023
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
Diego Bagnasco, Stefania Nicola, Elisa Testino, et al.
Page
of 8